Population
Enzymes (thrombin, trypsin, and plasmin) reacting with synthesized ester analogues
Comparison
p-nitrophenyl alpha-amino-p-toluate hydrobromide vs p-nitrophenyl p-guanidinobenzoate hydrochloride…
Design
Preclinical
Authors
Loading...
Acylation barriers, not binding, drive thrombin's arginyl preference; extends enzyme kinetics but leaves open physiologic or therapeutic translation.
Thrombin's specificity and limited cleavage of lysyl bonds are driven by restricted acylation rather than substrate binding, highlighting a stringent spatial requirement in its active site.
Ryan et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: